Pegylated granulocyte colony-stimulating factor conveys long-term neuroprotection and improves functional outcome in a model of Parkinson’s disease - Bertin Instruments

    Scientific publications

    Pegylated granulocyte colony-stimulating factor conveys long-term neuroprotection and improves functional outcome in a model of Parkinson’s disease

    1. Tobias Frank1,2, 2. Florian Klinker3, 3. Björn H. Falkenburger4, 4. Rico Laage5, 5. Fred Lühder6, 6. Bettina Göricke1,2, 7. Armin Schneider5, 8. Hartmud Neurath7, 9. Herbert Desel7, 10. David Liebetanz3, 11. Mathias Bähr1,2 and 12. Jochen H. Weishaupt1,2,*
    Sources: 1. 1 Department of Neurology, University Medical Centre, Georg-August-University, 37075 Göttingen, Germany2. 2 DFG-Research Centre for Molecular Physiology of the Brain (CMPB), 37075 Göttingen, Germany3. 3 Department of Clinical Neurophysiology, University Medical Centre, Georg-August-University, 37075 Göttingen, Germany4. 4 Department of Neurology, RWTH Aachen University, Aachen, Germany5. 5 Sygnis Bioscience, 69120 Heidelberg, Germany6. 6 Department of Neuroimmunology, Institute for Multiple Sclerosis Research and The Hertie Foundation, Georg-August-University, 37073 Göttingen, Germany 7. 7 GIZ-Nord Poisons Centre and Toxicology Laboratory, University Medical Centre, Georg-August-University, 37075 Göttingen, Germany
    Brain (2012) doi: 10.1093/brain/aws054 First published online: March 16, 2012, Received August 8, 2011. Revision received December 22, 2011. Accepted December 26, 2011.

    Sample name

    Animal tissues (mice brain)

    ANY QUESTIONS? CONTACT AN EXPERT

    Please fill in this form if you wish to contact our sales team or receive further information.

    My Account
    Forgot password ?

    Add a question !

    Add a question